- published: 13 Jul 2012
- views: 33408
Create your page here
-
remove the playlistGlaxosmithkline
- remove the playlistGlaxosmithkline
back to playlist
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, the illegal marketing of them, and the obscuring of clinical data from the FDA. "Today's multibillion dollar settlement is unprecedented in both size and scope," Deputy Attorney General James M. Cole said in a press conference.
The investigation unearthed at least a decade's worth of physician kickbacks, fraudulent marketing, and various other kinds of legal (and ethical) boundaries breached, though this kind of behavior seems par for the course across the industry: Last year, Johnson & Johnson, pleading guilty to bribing foreign doctors, agreed to fork up $70 million in fines. As of April, Bristol-Myers Squibb has been subpoenaed by the SEC (likely for something similar), and Merck, Eli Lilly, GlaxoSmithKline, and AstraZeneca have said they are also cooperating with investigations, according to the New York Times."
Read more: http://www.motherjones.com/blue-marble/2012/07/glaxosmithkline-fraud-docs
Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube
Like Us on Facebook:
Follow Us on Twitter: http://twitter.com/theyoungturks
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline and how GSK has developed them.
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
See more on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline
- published: 20 Oct 2011
- views: 38481
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the company recently pleaded guilty to felony crimes and paid a $3 billion settlement with the U.S. government.
In this Health Ranger Report video, Blair describes his firsthand knowledge of the "bribery" of physicians, the push for off-label marketing of drugs for unapproved health conditions, the illegal marketing of drugs to children, how 80 percent of physicians were willing to be "on the take," and much more.
More details at NaturalNews.com
- published: 17 Jul 2012
- views: 48216
A British corporate investigator who was jailed in Shanghai in relation to a massive corruption case against British pharmaceuticals giant GlaxoSmithKline -- has told the BBC he was shocked that he and his wife received a custodial sentence -- while senior GSK staff convicted of more serious charges -- did not. At the time the company did however pay fines of around $500 million. In an exclusive interview, Peter Humphrey also told our China Editor Carrie Gracie that the British government must educate companies to the risks they face in China.
Subscribe http://www.youtube.com/bbcnews
Check out our website: http://www.bbc.com/news
Facebook: http://www.facebook.com/bbcworldnews
Twitter: http://www.twitter.com/bbcworld
Instagram: http://instagram.com/bbcnews
- published: 10 Jul 2015
- views: 8469
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He speaks with Bloomberg's Erik Schatzker and Cynthia Koons on "What'd You Miss?"
- published: 04 Nov 2015
- views: 646
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals giant, GlaxoSmithKline after the company was found guilty in a bribery probe. CCTV America’s s Ritu Dixit reports.
- published: 20 Sep 2014
- views: 2273
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce Bello, Torian Graham, Ike Nwamu, Dorian Finney-Smith, Bishop Daniels, Marshall Plumlee, Josh Newkirk, T.J. Warren, Damarcus Harrison, Braxton Ogbueze, and Tyler Adams.
- published: 31 Dec 2010
- views: 88243
The drug company admitted to promoting its drugs for uses not approved by regulators. For More Information, Click Here: http://abcnews.go.com/Blotter/pharma-giant-gsk-pay-3b-illegally-marketing-drugs/story?id=16695205
- published: 03 Jul 2012
- views: 5562
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery Performance Unit
GlaxoSmithKline (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. Research is vitally important to the success of our business, and we spent just under £4 billion in 2012 in our search to develop new medicines. GSK has an established global Regenerative Medicine Discovery Performance Unit in R&D; which drives the discovery and development of regenerative medicines inside and outside GSK, including partnerships with The Harvard Stem Cell Institute (stem cell-based assays for drug discovery), and Telethon Institute for Gene Therapy (stem cell gene therapy for rare genetic diseases). Progress in these alliances will be presented together with the discovery and development of the approved GSK drug, Promacta, a small molecule activator of endogenous progenitor cells, as an example of new regenerative medicines.
For more information on the 2013 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com
- published: 24 Oct 2013
- views: 2503
Mohawks - GlaxoSmithKline Champions
The Mohawks ultimate frisbee team demonstrate how to play the new game sweeping the UK Uni Ultimate scene; GlaxoSmithKline, the game, nothing to do with GlaxoSmithKline, the company.
Includes 29 second world record which was subsequently smashed at GlaxoSmithKline Nationals 2006.
www.pushpass.co.uk
Director: Mac
- published: 28 Apr 2011
- views: 1812
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bribery of physicians, the push for off-label marketing of drugs for unapproved health conditions, and the illegal marketing of drugs to children by GlaxoSmithKline.
http://www.infowars.com/
http://www.prisonplanet.tv/
http://twitter.com/#!/RealAlexJones
http://www.facebook.com/AlexanderEmerikJones
[Check out Alex's New Social Network-'Planet Infowars'
http://planet.infowars.com/
Get all your Youngevity Products such as Beyond Tangy Tangerine, the Alex Pack and Pollen Burst. These supplements are a great way to get your essentials vitamins, minerals, amino acids, and other beneficial nutrients
http://www.infowarsteam.com/index.php?1942701
[[[ProPur Water Filtration]]]
http://www.infowarsshop.com/-ProPur-Water-Filtration_c_53.html
- published: 17 Jul 2012
- views: 12650
GlaxoSmithKline plc (GSK) (LSE: GSK, NYSE: GSK) is a British multinational pharmaceutical, biologics, vaccines, and consumer healthcare company headquartered in London, United Kingdom. It is the world's fourth-largest pharmaceutical company measured by 2009 prescription drug sales (after Pfizer, Novartis and Sanofi).
GSK has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes, and digestive conditions. It also has a large consumer healthcare division which produces and markets oral healthcare and nutritional products and over-the-counter medicines including Sensodyne, Boost, Horlicks, and Gaviscon.
GSK has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of December 2011, it had a market capitalisation of £73.8 billion, the fifth-largest of any company listed on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange.
GSK was formed in 2000 by the merger of GlaxoWellcome plc (formed from the acquisition of Wellcome plc by Glaxo plc), and SmithKline Beecham plc (from the merger of Beecham plc, and SmithKline Beckman Corporation).
This page contains text from Wikipedia, the Free Encyclopedia -
http://en.wikipedia.org/wiki/GlaxoSmithKline
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
6:35GlaxoSmithKline (GSK) Fined $3 Billion
GlaxoSmithKline (GSK) Fined $3 BillionGlaxoSmithKline (GSK) Fined $3 Billion
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, the illegal marketing of them, and the obscuring of clinical data from the FDA. "Today's multibillion dollar settlement is unprecedented in both size and scope," Deputy Attorney General James M. Cole said in a press conference. The investigation unearthed at least a decade's worth of physician kickbacks, fraudulent marketing, and various other kinds of legal (and ethical) boundaries breached, though this kind of behavior seems par for the course across the industry: Last year, Johnson & Johnson, pleading guilty to bribing foreign doctors, agreed to fork up $70 million in fines. As of April, Bristol-Myers Squibb has been subpoenaed by the SEC (likely for something similar), and Merck, Eli Lilly, GlaxoSmithKline, and AstraZeneca have said they are also cooperating with investigations, according to the New York Times." Read more: http://www.motherjones.com/blue-marble/2012/07/glaxosmithkline-fraud-docs Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube Like Us on Facebook: Follow Us on Twitter: http://twitter.com/theyoungturks -
2:45Why our graduates chose GSK
Why our graduates chose GSKWhy our graduates chose GSK
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline and how GSK has developed them. Follow @GSK on Twitter: http://twitter.com/GSK Like GSK on Facebook: http://www.facebook.com/GSK Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision See more on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline -
67:29GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugsGlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the company recently pleaded guilty to felony crimes and paid a $3 billion settlement with the U.S. government. In this Health Ranger Report video, Blair describes his firsthand knowledge of the "bribery" of physicians, the push for off-label marketing of drugs for unapproved health conditions, the illegal marketing of drugs to children, how 80 percent of physicians were willing to be "on the take," and much more. More details at NaturalNews.com -
55:47BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKlineBSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
-
4:01GlaxoSmithKline: GSK investigator warns over China - BBC News
GlaxoSmithKline: GSK investigator warns over China - BBC NewsGlaxoSmithKline: GSK investigator warns over China - BBC News
A British corporate investigator who was jailed in Shanghai in relation to a massive corruption case against British pharmaceuticals giant GlaxoSmithKline -- has told the BBC he was shocked that he and his wife received a custodial sentence -- while senior GSK staff convicted of more serious charges -- did not. At the time the company did however pay fines of around $500 million. In an exclusive interview, Peter Humphrey also told our China Editor Carrie Gracie that the British government must educate companies to the risks they face in China. Subscribe http://www.youtube.com/bbcnews Check out our website: http://www.bbc.com/news Facebook: http://www.facebook.com/bbcworldnews Twitter: http://www.twitter.com/bbcworld Instagram: http://instagram.com/bbcnews -
10:20GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
GlaxoSmithKline CEO: More Transparency Is Needed in Drug PricingGlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He speaks with Bloomberg's Erik Schatzker and Cynthia Koons on "What'd You Miss?" -
1:58GlaxoSmithKline Found Guilty of Bribery in China
GlaxoSmithKline Found Guilty of Bribery in ChinaGlaxoSmithKline Found Guilty of Bribery in China
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals giant, GlaxoSmithKline after the company was found guilty in a bribery probe. CCTV America’s s Ritu Dixit reports. -
2:31The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, EtcThe 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce Bello, Torian Graham, Ike Nwamu, Dorian Finney-Smith, Bishop Daniels, Marshall Plumlee, Josh Newkirk, T.J. Warren, Damarcus Harrison, Braxton Ogbueze, and Tyler Adams. -
2:11GlaxoSmithKline Fined $3 Billion
GlaxoSmithKline Fined $3 BillionGlaxoSmithKline Fined $3 Billion
The drug company admitted to promoting its drugs for uses not approved by regulators. For More Information, Click Here: http://abcnews.go.com/Blotter/pharma-giant-gsk-pay-3b-illegally-marketing-drugs/story?id=16695205 -
11:01GlaxoSmithKline (GSK) - Company Presentation
GlaxoSmithKline (GSK) - Company PresentationGlaxoSmithKline (GSK) - Company Presentation
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery Performance Unit GlaxoSmithKline (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. Research is vitally important to the success of our business, and we spent just under £4 billion in 2012 in our search to develop new medicines. GSK has an established global Regenerative Medicine Discovery Performance Unit in R&D; which drives the discovery and development of regenerative medicines inside and outside GSK, including partnerships with The Harvard Stem Cell Institute (stem cell-based assays for drug discovery), and Telethon Institute for Gene Therapy (stem cell gene therapy for rare genetic diseases). Progress in these alliances will be presented together with the discovery and development of the approved GSK drug, Promacta, a small molecule activator of endogenous progenitor cells, as an example of new regenerative medicines. For more information on the 2013 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com -
3:15GlaxoSmithKline
GlaxoSmithKlineGlaxoSmithKline
Mohawks - GlaxoSmithKline Champions The Mohawks ultimate frisbee team demonstrate how to play the new game sweeping the UK Uni Ultimate scene; GlaxoSmithKline, the game, nothing to do with GlaxoSmithKline, the company. Includes 29 second world record which was subsequently smashed at GlaxoSmithKline Nationals 2006. www.pushpass.co.uk Director: Mac -
45:18Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug MarketingInsider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bribery of physicians, the push for off-label marketing of drugs for unapproved health conditions, and the illegal marketing of drugs to children by GlaxoSmithKline. http://www.infowars.com/ http://www.prisonplanet.tv/ http://twitter.com/#!/RealAlexJones http://www.facebook.com/AlexanderEmerikJones [Check out Alex's New Social Network-'Planet Infowars' http://planet.infowars.com/ Get all your Youngevity Products such as Beyond Tangy Tangerine, the Alex Pack and Pollen Burst. These supplements are a great way to get your essentials vitamins, minerals, amino acids, and other beneficial nutrients http://www.infowarsteam.com/index.php?1942701 [[[ProPur Water Filtration]]] http://www.infowarsshop.com/-ProPur-Water-Filtration_c_53.html
- Aciclovir
- Acme Markets
- Admiral Group
- Aggreko
- AgustaWestland
- Airgas
- Albendazole
- Allen & Hanburys
- Alliance Boots
- AlliedBarton
- AMEC
- AmerisourceBergen
- Amoxicillin
- Andrew Mosholder
- Andrew Witty
- Anglo American plc
- Animal rights
- Antofagasta PLC
- Aplaviroc
- Aqua America
- Aquafresh
- Aramark
- ARM Holdings
- Ashland Inc.
- Ashmore Group
- Astex
- Asthma
- AstraZeneca
- Auckland
- Avandia
- Aviva
- BAE Systems
- Ballard Spahr
- Bandolier (journal)
- Barclays
- Barnard Castle
- Bayer
- BBC
- BC Powder
- Beconase
- Beecham's Pills
- Beneficial Bank
- Bentley Systems
- BG Group
- BHP Billiton
- Bill Lockyer
- Biopharmaceutical
- Biotechnology
- Biotene
- Blackcurrant
- Blackstone Group
- Blank Rome
- Block Drug
- Board of directors
- Boost (health food)
- Boronia
- Boscov's
- BP
- Brasov
- Brentford
- Bristol, Tennessee
- British Land
- BSkyB
- BT Group
- BTG
- Buckinghamshire
- Bunnythorpe
- Bunzl
- Bupropion
- Burberry
- Calcium carbonate
- Capita Group
- Carvedilol
- Cefuroxime
- Centocor
- Centrica
- Cephalon
- Chris Gent
- Chuck Grassley
- Cidra
- Cidra, Puerto Rico
- Cigna
- Cimetidine
- Clifton, New Jersey
- Colonial Penn
- Comcast
- Commerce Commission
- Compass Group
- Conseco
- Cork (city)
- Corporation
- Cozen O'Connor
- CRH plc
- Crispin Davis
- Croda International
- Crown Holdings
- Cyclacel
- Daniel Podolsky
- Dechert
- Delaware Valley
- Delmarva Power
- Deryck Maughan
- Dexedrine
- Diabetes
- Diageo
- Digestive disease
- Digoxin
- Dow Chemical
- Dresden
- DrugScope
- Duane Morris
- Dungarvan
- DuPont
- Dutasteride
- EBay
- Ecotrin
- Eliot Spitzer
- Eltrombopag
- Eno (drug)
- Evraz
- Evreux
- Exelon
- Experian
- Fair Go
- Fiber Choice
- Filariasis
- Financial Times
- Flonase
- Fluticasone
- Fluticasone furoate
- Fondaparinux
- Forman Mills
- Fortune 500
- Fresnillo plc
- FTSE 100 Index
- G4S
- Gaviscon
- GE Healthcare
- Genus plc
- Geritol
- Germany
- GKN
- GlaxoSmithKline
- GlaxoSmithKline plc
- Glencore
- Goody's Powder
- GSI Commerce
- Hammerson
- Hargreaves Lansdown
- Harlow
- Henry Wellcome
- Hercules Inc.
- Hewlett-Packard
- Horlicks
- HSBC
- HSBC Bank USA
- Ian Prosser
- Ibandronic acid
- ICAP (company)
- IFPMA
- IMI plc
- Imperial Tobacco
- India
- ING Group
- Intercytex
- International Power
- Intertek
- Iowa
- ITV plc
- John Buse
- John K. Smith
- Johnson & Johnson
- Johnson Matthey
- Judy Lewent
- Kazakhmys
- Kenya
- Kingfisher plc
- Lamotrigine
- Land Securities
- Lapatinib
- Laval, Quebec
- Lawrence Culp
- Legal & General
- Les Ulis
- Levetiracetam
- Liberty Media
- Lloyds Banking Group
- London
- Lovaza
- Lucozade
- MAB Paints
- Maharashtra
- Mahlon Kline
- Maidenhead
- Man Group
- Marks & Spencer
- Max Baucus
- Maxinutrition
- McNeil Laboratories
- Medicaid
- MedImmune
- Meggitt
- Mental health
- Mississauga, Ontario
- Moncef Slaoui
- Montrose, Angus
- Morrisons
- Naratriptan
- Nashik
- National Grid plc
- Nelarabine
- Neoware
- Net income
- New Jersey
- News & Observer
- Next (clothing)
- Nicoderm
- Nicorette
- Niquitin
- North Carolina
- Novartis
- NYSE
- Odds ratio
- OJSC Polymetal
- Old Mutual
- Ondansetron
- OpenCorporates
- Orlistat
- Oxford BioMedica
- Pakuranga College
- Panadol night
- Pandemrix
- Paracetamol
- Parma
- Paroxetine
- Patent Pool
- Paxil
- Pearson PLC
- PECO Energy Company
- Pennsylvania
- Pep Boys
- Pepco Holdings
- Pepper Hamilton
- Petrofac
- Pfizer
- Pfizer UK
- Pharmaceutical
- Pharmacogenomics
- Philadelphia
- Phytopharm
- Piboserod
- Pinnacle Foods
- Pittsburgh
- Polish Water Ice
- Portal Companies
- Pound sterling
- Poznań
- PR Newswire
- Prestige Brands
- Prudential plc
- PubMed Identifier
- Puerto Rico
- QVC
- R&D;
- Radian Group
- Ralgex
- Randgold Resources
- Ranitidine
- Reckitt Benckiser
- Reed Elsevier
- Renovo plc
- Resolution Limited
- Rexam
- Ribena
- Rio Tinto Group
- Rita's Italian Ice
- Rixensart
- Rohm and Haas
- Rolls-Royce plc
- Ropinirole
- Rosiglitazone
- Roy M. Anderson
- Royal Dutch Shell
- RSA Insurance Group
- SABMiller
- Sage Group
- Sainsbury's
- Salbutamol
- Sanofi
- SAP AG
- Saul Ewing
- Schroders
- Sensodyne
- Serco Group
- Severn Trent
- Sherwin-Williams
- Shire plc
- Sikorsky Aircraft
- Simon Dingemans
- Sir Andrew Witty
- Smith & Nephew
- SmithKline & French
- SmithKline Beecham
- Smiths Group
- Sominex
- Sovereign Bank
- SSE plc
- SSRI
- St. Louis, Missouri
- Stacey Cartwright
- Standard Chartered
- Standard Life
- Stephanie Burns
- Stevenage
- Stock exchange
- Stockley Park
- Subaru of America
- Sumatriptan
- SunGard
- Sunoco
- Synflorix
- Tagamet
- Tasty Baking Company
- Tate & Lyle
- TBS GB
- TD Bank, N.A.
- Tesco
- Thane
- The Vanguard Group
- Ticker symbol
- Tokyo
- Tom de Swaan
- Tranylcypromine
- Trizivir
- Tullow Oil
- Tums
- Twinrix
- UGI Corporation
- Ulverston
- Unilever
- Unipath
- Unisys
- United Kingdom
- United Utilities
- Urban Outfitters
- Vaccine
- Valaciclovir
- Vardenafil
- Vectura Group
- Vedanta Resources
- Vernalis plc
- ViiV Healthcare
- ViroPharma
- Vitamin C
- Vodafone
- Ware, Hertfordshire
- Wavre
- Wawa Food Market
- Weir Group
- Whitbread
- Wilmington Trust
- Wolseley plc
- Worthing
- WPP plc
- WSFS Bank
- Xstrata
- Zagreb
- Zanamivir
- Zidovudine
- Auckland
- BAE Systems
- Barnard Castle
- Brentford
- BSkyB
- Buckinghamshire
- Bunnythorpe
- Delaware Valley
- Dungarvan
- Germany
- Harlow
- India
- Iowa
- Kenya
- Les Ulis
- London
- Maharashtra
- Maidenhead
- Nashik
- New Jersey
- North Carolina
- Parma
- Pennsylvania
- Philadelphia
- Pittsburgh
- Poznań
- Puerto Rico
- Standard Life
- Stevenage
- Stockley Park
- Tesco
- Thane
- Tokyo
- Ulverston
- United Kingdom
- Worthing
- Zagreb
-
GlaxoSmithKline (GSK) Fined $3 Billion
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, the illegal marketing of them, and the obscuring of clinical data from the FDA. "Today's multibillion dollar settlement is unprecedented in both size and scope," Deputy Attorney General James M. Cole said in a press conference. The investigation unearthed at least a decade's worth of physician kickbacks, fraudulent marketing, and various other kinds of legal (and ethical) boundaries breached, though this kind of behavior seems par for the course across the industry: Last year, Johnson & Johnson, pleading guilty to bribing foreign doctors, agreed to fork up $70 million in fines. As of April, Bristol-Myers Squibb has been subpoenaed b... -
Why our graduates chose GSK
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline and how GSK has developed them. Follow @GSK on Twitter: http://twitter.com/GSK Like GSK on Facebook: http://www.facebook.com/GSK Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision See more on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline -
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the company recently pleaded guilty to felony crimes and paid a $3 billion settlement with the U.S. government. In this Health Ranger Report video, Blair describes his firsthand knowledge of the "bribery" of physicians, the push for off-label marketing of drugs for unapproved health conditions, the illegal marketing of drugs to children, how 80 percent of physicians were willing to be "on the take," and much more. More details at NaturalNews.com -
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
-
GlaxoSmithKline: GSK investigator warns over China - BBC News
A British corporate investigator who was jailed in Shanghai in relation to a massive corruption case against British pharmaceuticals giant GlaxoSmithKline -- has told the BBC he was shocked that he and his wife received a custodial sentence -- while senior GSK staff convicted of more serious charges -- did not. At the time the company did however pay fines of around $500 million. In an exclusive interview, Peter Humphrey also told our China Editor Carrie Gracie that the British government must educate companies to the risks they face in China. Subscribe http://www.youtube.com/bbcnews Check out our website: http://www.bbc.com/news Facebook: http://www.facebook.com/bbcworldnews Twitter: http://www.twitter.com/bbcworld Instagram: http://instagram.com/bbcnews -
GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He speaks with Bloomberg's Erik Schatzker and Cynthia Koons on "What'd You Miss?" -
GlaxoSmithKline Found Guilty of Bribery in China
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals giant, GlaxoSmithKline after the company was found guilty in a bribery probe. CCTV America’s s Ritu Dixit reports. -
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce Bello, Torian Graham, Ike Nwamu, Dorian Finney-Smith, Bishop Daniels, Marshall Plumlee, Josh Newkirk, T.J. Warren, Damarcus Harrison, Braxton Ogbueze, and Tyler Adams. -
GlaxoSmithKline Fined $3 Billion
The drug company admitted to promoting its drugs for uses not approved by regulators. For More Information, Click Here: http://abcnews.go.com/Blotter/pharma-giant-gsk-pay-3b-illegally-marketing-drugs/story?id=16695205 -
GlaxoSmithKline (GSK) - Company Presentation
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery Performance Unit GlaxoSmithKline (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. Research is vitally important to the success of our business, and we spent just under £4 billion in 2012 in our search to develop new medicines. GSK has an established global Regenerative Medicine Dis... -
GlaxoSmithKline
Mohawks - GlaxoSmithKline Champions The Mohawks ultimate frisbee team demonstrate how to play the new game sweeping the UK Uni Ultimate scene; GlaxoSmithKline, the game, nothing to do with GlaxoSmithKline, the company. Includes 29 second world record which was subsequently smashed at GlaxoSmithKline Nationals 2006. www.pushpass.co.uk Director: Mac -
Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bribery of physicians, the push for off-label marketing of drugs for unapproved health conditions, and the illegal marketing of drugs to children by GlaxoSmithKline. http://www.infowars.com/ http://www.prisonplanet.tv/ http://twitter.com/#!/RealAlexJones http://www.facebook.com/AlexanderEmerikJones [Check out Alex's New Social Network-'Planet Infowars' http://planet.infowars.com/ Get all your Youngevity Products such as Beyond Tangy Tangerine, the Alex Pack and Pollen Burst. These supplements are a great way to get your essentials vitamins, minerals, amino acids, and other beneficial nutrients http://www.infowarsteam.com/index.php?1942701 [[[ProPur Water Filtration]]] http://www.infowarss...
GlaxoSmithKline (GSK) Fined $3 Billion
- Order: Reorder
- Duration: 6:35
- Updated: 13 Jul 2012
- views: 33408
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, t...
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, the illegal marketing of them, and the obscuring of clinical data from the FDA. "Today's multibillion dollar settlement is unprecedented in both size and scope," Deputy Attorney General James M. Cole said in a press conference.
The investigation unearthed at least a decade's worth of physician kickbacks, fraudulent marketing, and various other kinds of legal (and ethical) boundaries breached, though this kind of behavior seems par for the course across the industry: Last year, Johnson & Johnson, pleading guilty to bribing foreign doctors, agreed to fork up $70 million in fines. As of April, Bristol-Myers Squibb has been subpoenaed by the SEC (likely for something similar), and Merck, Eli Lilly, GlaxoSmithKline, and AstraZeneca have said they are also cooperating with investigations, according to the New York Times."
Read more: http://www.motherjones.com/blue-marble/2012/07/glaxosmithkline-fraud-docs
Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube
Like Us on Facebook:
Follow Us on Twitter: http://twitter.com/theyoungturks
wn.com/Glaxosmithkline (Gsk) Fined 3 Billion
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of $3 billion to resolve allegations pertaining to several other drugs, the illegal marketing of them, and the obscuring of clinical data from the FDA. "Today's multibillion dollar settlement is unprecedented in both size and scope," Deputy Attorney General James M. Cole said in a press conference.
The investigation unearthed at least a decade's worth of physician kickbacks, fraudulent marketing, and various other kinds of legal (and ethical) boundaries breached, though this kind of behavior seems par for the course across the industry: Last year, Johnson & Johnson, pleading guilty to bribing foreign doctors, agreed to fork up $70 million in fines. As of April, Bristol-Myers Squibb has been subpoenaed by the SEC (likely for something similar), and Merck, Eli Lilly, GlaxoSmithKline, and AstraZeneca have said they are also cooperating with investigations, according to the New York Times."
Read more: http://www.motherjones.com/blue-marble/2012/07/glaxosmithkline-fraud-docs
Support The Young Turks by Subscribing http://bit.ly/TYTonYouTube
Like Us on Facebook:
Follow Us on Twitter: http://twitter.com/theyoungturks
- published: 13 Jul 2012
- views: 33408
Why our graduates chose GSK
- Order: Reorder
- Duration: 2:45
- Updated: 20 Oct 2011
- views: 38481
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline and how GSK has developed them.
Follow @GSK on Twitter: http://twitter...
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline and how GSK has developed them.
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
See more on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline
wn.com/Why Our Graduates Chose Gsk
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline and how GSK has developed them.
Follow @GSK on Twitter: http://twitter.com/GSK
Like GSK on Facebook: http://www.facebook.com/GSK
Follow GSK on LinkedIn: http://www.linkedin.com/company/glaxosmithkline
Subscribe to GSK on YouTube: http://www.youtube.com/subscription_center?add_user=gskvision
See more on GSK Flickr: http://www.flickr.com/photos/glaxosmithkline
- published: 20 Oct 2011
- views: 38481
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
- Order: Reorder
- Duration: 67:29
- Updated: 17 Jul 2012
- views: 48216
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the company...
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the company recently pleaded guilty to felony crimes and paid a $3 billion settlement with the U.S. government.
In this Health Ranger Report video, Blair describes his firsthand knowledge of the "bribery" of physicians, the push for off-label marketing of drugs for unapproved health conditions, the illegal marketing of drugs to children, how 80 percent of physicians were willing to be "on the take," and much more.
More details at NaturalNews.com
wn.com/Glaxosmithkline Whistleblower Speaks Out About Bribery Of Doctors, Off Label Marketing Of Drugs
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamrick reveals insider details of GSK's operations, for which the company recently pleaded guilty to felony crimes and paid a $3 billion settlement with the U.S. government.
In this Health Ranger Report video, Blair describes his firsthand knowledge of the "bribery" of physicians, the push for off-label marketing of drugs for unapproved health conditions, the illegal marketing of drugs to children, how 80 percent of physicians were willing to be "on the take," and much more.
More details at NaturalNews.com
- published: 17 Jul 2012
- views: 48216
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
- Order: Reorder
- Duration: 55:47
- Updated: 11 Nov 2014
- views: 8626
- published: 11 Nov 2014
- views: 8626
GlaxoSmithKline: GSK investigator warns over China - BBC News
- Order: Reorder
- Duration: 4:01
- Updated: 10 Jul 2015
- views: 8469
A British corporate investigator who was jailed in Shanghai in relation to a massive corruption case against British pharmaceuticals giant GlaxoSmithKline -- ha...
A British corporate investigator who was jailed in Shanghai in relation to a massive corruption case against British pharmaceuticals giant GlaxoSmithKline -- has told the BBC he was shocked that he and his wife received a custodial sentence -- while senior GSK staff convicted of more serious charges -- did not. At the time the company did however pay fines of around $500 million. In an exclusive interview, Peter Humphrey also told our China Editor Carrie Gracie that the British government must educate companies to the risks they face in China.
Subscribe http://www.youtube.com/bbcnews
Check out our website: http://www.bbc.com/news
Facebook: http://www.facebook.com/bbcworldnews
Twitter: http://www.twitter.com/bbcworld
Instagram: http://instagram.com/bbcnews
wn.com/Glaxosmithkline Gsk Investigator Warns Over China BBC News
A British corporate investigator who was jailed in Shanghai in relation to a massive corruption case against British pharmaceuticals giant GlaxoSmithKline -- has told the BBC he was shocked that he and his wife received a custodial sentence -- while senior GSK staff convicted of more serious charges -- did not. At the time the company did however pay fines of around $500 million. In an exclusive interview, Peter Humphrey also told our China Editor Carrie Gracie that the British government must educate companies to the risks they face in China.
Subscribe http://www.youtube.com/bbcnews
Check out our website: http://www.bbc.com/news
Facebook: http://www.facebook.com/bbcworldnews
Twitter: http://www.twitter.com/bbcworld
Instagram: http://instagram.com/bbcnews
- published: 10 Jul 2015
- views: 8469
GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
- Order: Reorder
- Duration: 10:20
- Updated: 04 Nov 2015
- views: 646
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He spea...
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He speaks with Bloomberg's Erik Schatzker and Cynthia Koons on "What'd You Miss?"
wn.com/Glaxosmithkline Ceo More Transparency Is Needed In Drug Pricing
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's growth prospects, the Pfizer-Allergan talks and drug pricing. He speaks with Bloomberg's Erik Schatzker and Cynthia Koons on "What'd You Miss?"
- published: 04 Nov 2015
- views: 646
GlaxoSmithKline Found Guilty of Bribery in China
- Order: Reorder
- Duration: 1:58
- Updated: 20 Sep 2014
- views: 2273
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals giant, GlaxoSmithKline after the company was found guilty in a bribery...
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals giant, GlaxoSmithKline after the company was found guilty in a bribery probe. CCTV America’s s Ritu Dixit reports.
wn.com/Glaxosmithkline Found Guilty Of Bribery In China
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals giant, GlaxoSmithKline after the company was found guilty in a bribery probe. CCTV America’s s Ritu Dixit reports.
- published: 20 Sep 2014
- views: 2273
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
- Order: Reorder
- Duration: 2:31
- Updated: 31 Dec 2010
- views: 88243
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce Bello, Torian Graham, Ike Nwamu, Dorian Finney-Smith, Bishop Daniels, M...
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce Bello, Torian Graham, Ike Nwamu, Dorian Finney-Smith, Bishop Daniels, Marshall Plumlee, Josh Newkirk, T.J. Warren, Damarcus Harrison, Braxton Ogbueze, and Tyler Adams.
wn.com/The 2010 Glaxosmithkline Recap Ft. Torian Graham, Deuce Bello, Etc
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce Bello, Torian Graham, Ike Nwamu, Dorian Finney-Smith, Bishop Daniels, Marshall Plumlee, Josh Newkirk, T.J. Warren, Damarcus Harrison, Braxton Ogbueze, and Tyler Adams.
- published: 31 Dec 2010
- views: 88243
GlaxoSmithKline Fined $3 Billion
- Order: Reorder
- Duration: 2:11
- Updated: 03 Jul 2012
- views: 5562
The drug company admitted to promoting its drugs for uses not approved by regulators. For More Information, Click Here: http://abcnews.go.com/Blotter/pharma-gia...
The drug company admitted to promoting its drugs for uses not approved by regulators. For More Information, Click Here: http://abcnews.go.com/Blotter/pharma-giant-gsk-pay-3b-illegally-marketing-drugs/story?id=16695205
wn.com/Glaxosmithkline Fined 3 Billion
The drug company admitted to promoting its drugs for uses not approved by regulators. For More Information, Click Here: http://abcnews.go.com/Blotter/pharma-giant-gsk-pay-3b-illegally-marketing-drugs/story?id=16695205
- published: 03 Jul 2012
- views: 5562
GlaxoSmithKline (GSK) - Company Presentation
- Order: Reorder
- Duration: 11:01
- Updated: 24 Oct 2013
- views: 2503
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery Performance Unit
GlaxoSmithKline (GSK) is a science-led global healthca...
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery Performance Unit
GlaxoSmithKline (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. Research is vitally important to the success of our business, and we spent just under £4 billion in 2012 in our search to develop new medicines. GSK has an established global Regenerative Medicine Discovery Performance Unit in R&D; which drives the discovery and development of regenerative medicines inside and outside GSK, including partnerships with The Harvard Stem Cell Institute (stem cell-based assays for drug discovery), and Telethon Institute for Gene Therapy (stem cell gene therapy for rare genetic diseases). Progress in these alliances will be presented together with the discovery and development of the approved GSK drug, Promacta, a small molecule activator of endogenous progenitor cells, as an example of new regenerative medicines.
For more information on the 2013 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com
wn.com/Glaxosmithkline (Gsk) Company Presentation
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery Performance Unit
GlaxoSmithKline (GSK) is a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. We have three primary areas of business in pharmaceuticals, vaccines and consumer healthcare. Our commercial success depends on creating innovative new products and making these accessible to as many people who need them as possible. Research is vitally important to the success of our business, and we spent just under £4 billion in 2012 in our search to develop new medicines. GSK has an established global Regenerative Medicine Discovery Performance Unit in R&D; which drives the discovery and development of regenerative medicines inside and outside GSK, including partnerships with The Harvard Stem Cell Institute (stem cell-based assays for drug discovery), and Telethon Institute for Gene Therapy (stem cell gene therapy for rare genetic diseases). Progress in these alliances will be presented together with the discovery and development of the approved GSK drug, Promacta, a small molecule activator of endogenous progenitor cells, as an example of new regenerative medicines.
For more information on the 2013 Stem Cell Meeting on the Mesa visit www.stemcellmeetingonthemesa.com
- published: 24 Oct 2013
- views: 2503
GlaxoSmithKline
- Order: Reorder
- Duration: 3:15
- Updated: 28 Apr 2011
- views: 1812
Mohawks - GlaxoSmithKline Champions
The Mohawks ultimate frisbee team demonstrate how to play the new game sweeping the UK Uni Ultimate scene; GlaxoSmithKline,...
Mohawks - GlaxoSmithKline Champions
The Mohawks ultimate frisbee team demonstrate how to play the new game sweeping the UK Uni Ultimate scene; GlaxoSmithKline, the game, nothing to do with GlaxoSmithKline, the company.
Includes 29 second world record which was subsequently smashed at GlaxoSmithKline Nationals 2006.
www.pushpass.co.uk
Director: Mac
wn.com/Glaxosmithkline
Mohawks - GlaxoSmithKline Champions
The Mohawks ultimate frisbee team demonstrate how to play the new game sweeping the UK Uni Ultimate scene; GlaxoSmithKline, the game, nothing to do with GlaxoSmithKline, the company.
Includes 29 second world record which was subsequently smashed at GlaxoSmithKline Nationals 2006.
www.pushpass.co.uk
Director: Mac
- published: 28 Apr 2011
- views: 1812
Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
- Order: Reorder
- Duration: 45:18
- Updated: 17 Jul 2012
- views: 12650
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bribery of physicians, the push for off-label marketing of drugs for unap...
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bribery of physicians, the push for off-label marketing of drugs for unapproved health conditions, and the illegal marketing of drugs to children by GlaxoSmithKline.
http://www.infowars.com/
http://www.prisonplanet.tv/
http://twitter.com/#!/RealAlexJones
http://www.facebook.com/AlexanderEmerikJones
[Check out Alex's New Social Network-'Planet Infowars'
http://planet.infowars.com/
Get all your Youngevity Products such as Beyond Tangy Tangerine, the Alex Pack and Pollen Burst. These supplements are a great way to get your essentials vitamins, minerals, amino acids, and other beneficial nutrients
http://www.infowarsteam.com/index.php?1942701
[[[ProPur Water Filtration]]]
http://www.infowarsshop.com/-ProPur-Water-Filtration_c_53.html
wn.com/Insider Reveals Glaxosmithkline Targeted Children With Illegal Drug Marketing
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bribery of physicians, the push for off-label marketing of drugs for unapproved health conditions, and the illegal marketing of drugs to children by GlaxoSmithKline.
http://www.infowars.com/
http://www.prisonplanet.tv/
http://twitter.com/#!/RealAlexJones
http://www.facebook.com/AlexanderEmerikJones
[Check out Alex's New Social Network-'Planet Infowars'
http://planet.infowars.com/
Get all your Youngevity Products such as Beyond Tangy Tangerine, the Alex Pack and Pollen Burst. These supplements are a great way to get your essentials vitamins, minerals, amino acids, and other beneficial nutrients
http://www.infowarsteam.com/index.php?1942701
[[[ProPur Water Filtration]]]
http://www.infowarsshop.com/-ProPur-Water-Filtration_c_53.html
- published: 17 Jul 2012
- views: 12650
close fullscreen
- Playlist
- Chat
close fullscreen
- Playlist
- Chat
6:35
GlaxoSmithKline (GSK) Fined $3 Billion
"Last week, GlaxoSmithKline agreed to plead guilty to criminal charges and pay a total of ...
published: 13 Jul 2012
GlaxoSmithKline (GSK) Fined $3 Billion
GlaxoSmithKline (GSK) Fined $3 Billion
- Report rights infringement
- published: 13 Jul 2012
- views: 33408
2:45
Why our graduates chose GSK
A video montage which answers the 'Big Questions' of why graduates chose GlaxoSmithKline a...
published: 20 Oct 2011
Why our graduates chose GSK
Why our graduates chose GSK
- Report rights infringement
- published: 20 Oct 2011
- views: 38481
67:29
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
This exclusive interview with former GlaxoSmithKline employee and whistleblower Blair Hamr...
published: 17 Jul 2012
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
GlaxoSmithKline whistleblower speaks out about bribery of doctors, off-label marketing of drugs
- Report rights infringement
- published: 17 Jul 2012
- views: 48216
55:47
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
published: 11 Nov 2014
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSmithKline
- Report rights infringement
- published: 11 Nov 2014
- views: 8626
4:01
GlaxoSmithKline: GSK investigator warns over China - BBC News
A British corporate investigator who was jailed in Shanghai in relation to a massive corru...
published: 10 Jul 2015
GlaxoSmithKline: GSK investigator warns over China - BBC News
GlaxoSmithKline: GSK investigator warns over China - BBC News
- Report rights infringement
- published: 10 Jul 2015
- views: 8469
10:20
GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
Nov. 3 -- Andrew Witty, GlaxoSmithKline's chief executive officer, discusses the company's...
published: 04 Nov 2015
GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
GlaxoSmithKline CEO: More Transparency Is Needed in Drug Pricing
- Report rights infringement
- published: 04 Nov 2015
- views: 646
1:58
GlaxoSmithKline Found Guilty of Bribery in China
A court in China has imposed a nearly half billion dollar fine on British Pharmaceuticals ...
published: 20 Sep 2014
GlaxoSmithKline Found Guilty of Bribery in China
GlaxoSmithKline Found Guilty of Bribery in China
- Report rights infringement
- published: 20 Sep 2014
- views: 2273
2:31
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
Here is the video recap of the 2010 GlaxoSmithKline Holiday Invitational featuring Deuce B...
published: 31 Dec 2010
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, Deuce Bello, Etc
- Report rights infringement
- published: 31 Dec 2010
- views: 88243
2:11
GlaxoSmithKline Fined $3 Billion
The drug company admitted to promoting its drugs for uses not approved by regulators. For ...
published: 03 Jul 2012
GlaxoSmithKline Fined $3 Billion
GlaxoSmithKline Fined $3 Billion
- Report rights infringement
- published: 03 Jul 2012
- views: 5562
11:01
GlaxoSmithKline (GSK) - Company Presentation
Presented by: Jason Gardner, D.Phil., VP of R&D;, Head of Regenerative Medicine Discovery P...
published: 24 Oct 2013
GlaxoSmithKline (GSK) - Company Presentation
GlaxoSmithKline (GSK) - Company Presentation
- Report rights infringement
- published: 24 Oct 2013
- views: 2503
3:15
GlaxoSmithKline
Mohawks - GlaxoSmithKline Champions
The Mohawks ultimate frisbee team demonstrate how to ...
published: 28 Apr 2011
GlaxoSmithKline
GlaxoSmithKline
- Report rights infringement
- published: 28 Apr 2011
- views: 1812
45:18
Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
Mike talks with Blair Hamrick, a big pharm whistleblower who has blown the lid off the bri...
published: 17 Jul 2012
Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
Insider Reveals GlaxoSmithKline Targeted Children with Illegal Drug Marketing
- Report rights infringement
- published: 17 Jul 2012
- views: 12650
GlaxoSmithKline (GSK) Fined $3 Billion...
Why our graduates chose GSK...
GlaxoSmithKline whistleblower speaks out about bri...
BSR Conference 2014: Sir Andrew Witty, CEO GlaxoSm...
GlaxoSmithKline: GSK investigator warns over China...
GlaxoSmithKline CEO: More Transparency Is Needed i...
GlaxoSmithKline Found Guilty of Bribery in China...
The 2010 GlaxoSmithKline Recap Ft. Torian Graham, ...
GlaxoSmithKline Fined $3 Billion...
GlaxoSmithKline (GSK) - Company Presentation...
GlaxoSmithKline...
Insider Reveals GlaxoSmithKline Targeted Children ...
-
Lyrics list:lyrics
-
Glaxo-smithkline
Glaxo-smithkline
Money for life,
Profit for lies,
Monopolised,
And capitalise our lives.
Glaxosmithcline
Hold back the rights,
Push up the place,
Ignore their plights,
And make out they're on our side,
On our side,
Take back what you gave,
We'll find another way,
To take away our pain,
With every word you say,
You make out we are safe,
That we are saved,
Clutched from the grave
Were watching as you trade,
Money for life,
Profit for lies,
Monopolised,
And capitalise,
Money for life,
Profit for lies,
Monopolised,
And capitalised our lives,
photo: WN / Sweet Radoc
Burgers contain rat and human DNA, study finds
Edit The Independent 11 May 2016photo: United States Department of Health and Human Services / Len Rizzi
Trump: Budweiser So Impressed What Country Will Become Changed Name To America
Edit WorldNews.com 11 May 2016
“I think so, they’re so impressed with what our country will become that they decided to do this before the fact.” – Republican presidential candidate Donald Trump. Anheuser-Busch announced the Budweiser name change and rebranding on Tuesday, saying it was repackaging 12-ounce bottles and cans with “America” from May 23 through the November election....
photo: AP / Associated Press Photo
Report: ISIS Android Alphabet App Appears Harmless, But Has Hidden Dangers
Edit WorldNews.com 11 May 2016
According to the jihadi monitoring site Vocativ, the app cannot be downloaded in the Google Store but only using AKP files that are being shared among the group’s supporters.ISIS has previously released apps, such as its “jihadist news feed” in November 2015, and a radio app in February that broadcasts the group’s propaganda....
photo: NASA / JHU APL/Carnegie Institution of Washington
[VIDEO]: Researchers Combine More Than 100,000 Images To Map Out Mercury
Edit WorldNews.com 11 May 2016
Using new space-age software, researchers have released the first topographical map of Mercury’s entire surface, providing a highly detailed view of the planet’s craters and volcanoes, a Business Insider report of a Christian Science Monitor story said ... The maps and animation offer a closer look at the planet’s highest and lowest points ... That point is more than three miles below Mercury’s average elevation, USGS says in its statement ... ....
photo: Creative Commons / Presse03
Surplus Killings: When Wolves Behave Like Humans
Edit WorldNews.com 11 May 2016
Wasteful killings over time can in reality cause starvation among an entire pack. Scientists Puzzled Over Rare Surplus KillingTherefore, scientists were puzzled when a pack of gray wolves in northwestern Wyoming committed a rare occurrence ... Officials were also concerned the killings, two adult cows and nine calves, would cause unfounded fears among ranchers and hunters ... Animal nature is seldom wasteful ... It is displaced ... March, 2016. ....
« back to news headlines
AGM Trading Update (Hikma Pharmaceuticals plc)
Edit Public Technologies 12 May 2016
(Source. Hikma Pharmaceuticals plc). London, 12 May 2016 - Hikma Pharmaceuticals PLC ('Hikma' or 'the Group')(LSE. HIK) (NASDAQ Dubai. HIK) (OTC ... Group ... Injectables. Our Injectables business is performing well ... Food and Drug Administration (FDA) that our abbreviated new drug application (ANDA) for fluticasone propionate and salmeterol inhalation powder (the generic version of GlaxoSmithKline's Advair Diskus®) has been accepted for filing....
Should you sell GlaxoSmithKline plc for this reason?
Edit The Motley Fool 11 May 2016
More reading Is it time to bail out of easyJet plc and buy GlaxoSmithKline plc instead? GlaxoSmithKline plc’s lead over AstraZeneca plc hits 20% and there’s more to come Is GlaxoSmithKline plc about to bomb? Why GlaxoSmithKline plc, 3i Group plc and Barratt Developments plc should outperform the FTSE 100! The numbers don’t lie, GlaxoSmithKline plc is set to beat AstraZeneca plc this year....
Why you should — and shouldn’t — pile into GlaxoSmithKline plc
Edit The Motley Fool 11 May 2016
More reading Should you sell GlaxoSmithKline plc for this reason? Is it time to bail out of easyJet plc and buy GlaxoSmithKline plc instead? GlaxoSmithKline plc’s lead over AstraZeneca plc hits 20% and there’s more to come Is GlaxoSmithKline plc about to bomb? Why GlaxoSmithKline plc, 3i Group plc and Barratt Developments plc should outperform the FTSE 100!....
Block listing Interim Review (GSK - GlaxoSmithKline plc)
Edit Public Technologies 11 May 2016
GSK - GlaxoSmithKline plc) ... GlaxoSmithKline plc ... GlaxoSmithKline Share Option Plan - Ordinary Shares ... GlaxoSmithKline plc ... GlaxoSmithKline Share Option Plan - ADS ... GlaxoSmithKline plc ... GlaxoSmithKline plc ... GlaxoSmithKline plc ... GlaxoSmithKline plc ... GlaxoSmithKline plc ... GlaxoSmithKline plc ... GlaxoSmithKline plc ... GlaxoSmithKline Savings Related Share Option Scheme ... GlaxoSmithKline plc ... GlaxoSmithKline plc Sharesave Plan 2012....
France gets G7 to discuss global regulation of medicine prices
Edit Graphic 11 May 2016
Any regulation would have to balance the need to keep costs down with the need for pharmaceutical companies like U.S group Pfizer, France's Sanofi or Britain's GlaxoSmithKline to retain financial incentives for innovation ... In the latest move by the pharmaceuticals industry to address criticism on prices, GlaxoSmithKline said in March it ......
The ONE thing you need to know to succeed in the market
Edit The Motley Fool 11 May 2016
The preservation of capital ... More reading 4 shares for a Donald Trump presidency? Why you should — and shouldn’t — pile into GlaxoSmithKline plc Read this before you buy BP plc, Unilever plc & Royal Bank of Scotland plc! Why dividends are primed to detonate at Aviva plc, Tritax Big Box REIT plc & Marks and Spencer Group plc! Are Gulf Keystone Petroleum Limited, Cape plc & Antofagasta plc about to crash to zero?....
Augmenting Demand for Fluoxetine in China Led by Rising Cases of Depression : Ken Research
Edit Community news 11 May 2016
· Rising cases of suicide death toll of depression around the world is up to 1.0 million people and the number of depression patients in China has reached 90 million ... There is a broad demand of Fluoxetine in China ... The leading players within the global antidepressants industry include Wyeth, GlaxoSmithKline, Pfizer, Forest Laboratories, AstraZeneca, Eli Lilly, Bristol-Myers Squibb Company, Schering-Plough and H. Lundbeck ... ... Contact.....
Why FTSE 100 dynamos AstraZeneca plc, GKN plc and Diageo plc should deliver stunning long-term growth!
Edit The Motley Fool 11 May 2016
Car star ... Lloyds Banking Group plc, Imperial Brands plc and Legal & General Group plc Will HSBC Holdings plc & Capita plc help you retire early? Why I’m expecting FTSE 100 losers Barclays plc (-30%), Prudential plc (-12%) and ARM Holdings plc (-9%) to bite back! Why investors should cheer if the FTSE 100 slumps to 5,000 points GlaxoSmithKline plc’s lead over AstraZeneca plc hits 20% and there’s more to come ... ....
May 11, 2016Innovus Pharma (INNV): Targeting $3+ Billion Markets With 13 Commercial Products (Innovus Pharmaceuticals Inc)
Edit Public Technologies 11 May 2016
(Source. Innovus Pharmaceuticals Inc). SAN DIEGO, CA--(Marketwired - May 11, 2016) - Most micro- and small-cap biotechnology firms are development-stage opportunities with a lengthy commercialization timeline ... Innovus Pharmaceuticals Inc. (OTCQB ... In addition, the Company is awaiting approval for its FlutiCare™ OTC drug (a GlaxoSmithKline Flonase competitor) for allergic rhinitis, a market that exceeds 1 billion dollars ... Bassam Damaj ... FDA....
Director/PDMR Shareholding (GSK - GlaxoSmithKline plc)
Edit Public Technologies 10 May 2016
GSK - GlaxoSmithKline plc). GlaxoSmithKline plc ... GSK - GlaxoSmithKline plc published this content on 10 May 2016 and is solely responsible for the information contained herein ... Original documenthttp.//otp.investis.com/clients/uk/GlaxoSmithKline/rns/regulatory-story.aspx?cid=410&newsid=720994....
Is it time to bail out of easyJet plc and buy GlaxoSmithKline plc instead?
Edit The Motley Fool 10 May 2016
Pharmaceutical giant GlaxoSmithKline (LSE ... The stable nature of demand for medicines makes GlaxoSmithKline’s operation far less cyclical and keeps the cash taps flowing as consumers repeat purchase drugs ... At today’s 1,475p share price GlaxoSmithKline trades on a forward P/E rating of just over 16 for 2017 and yields a dividend of 5.4% covered just over once by forward earnings....
GlaxoSmithKline plc’s lead over AstraZeneca plc hits 20% and there’s more to come
Edit The Motley Fool 10 May 2016
The UK’s two leading pharma companies are GlaxoSmithKline (LSE ... GlaxoSmithKline plc about to bomb? Why GlaxoSmithKline plc, 3i Group plc and Barratt Developments plc should outperform the FTSE 100! What makes the perfect portfolio?. Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline....
Unbowed Pfizer ponders inversions but a spinoff may be a better plan
Edit Business Day 10 May 2016
... GlaxoSmithKline in good health....
- 1
- 2
- 3
- 4
- 5
- Next page »
